International Journal of Clinical Pharmacy

, Volume 41, Issue 5, pp 1133–1137 | Cite as

Overuse of intravenous infusions in China: focusing on management platform and cultural problems

  • Shuangshuang Zeng
  • Dong Wang
  • Wanli Liu
  • Yuanliang Yan
  • Minwen Zhu
  • Zhicheng GongEmail author
  • Shusen SunEmail author


This article reviews the current status of the overuse of intravenous (IV) infusions in China and implications to patient safety, and analyzes factors associated with the overuse. Although many factors contribute to the overuse of IV infusions in China, we focus on the construction of an IV infusion management system and tackling cultural problems as the first step to address issues of IV therapy in this commentary.


China Cultural problems Infusion management platform Intravenous infusions Overuse Rational use 



The authors received no funding in connection with the paper.

Conflicts of interest

All authors declare that they have no conflicts of interest.


  1. 1.
    Zeng S, Wang D, Yan Y, Zhu M, Liu W, Gomg Z, Wang L, Sun S. Single-center analysis of the potential inappropriate use of intravenous medications in hospitalized patients in China. Clin Ther. 2019. Scholar
  2. 2.
    Wang H, Xie X, Liu Z, Yang Z. Evaluation of the inpatient usage of intravenous infusion in 156 hospitals. J Pharm Pract. 2017;35(6):573–6.Google Scholar
  3. 3.
    Gao X, Chen L, Deng R, Xia Y, Chen J, Chen X. Current situation, hazards and countermeasures against the overuse of intravenous infusion. Progr Pharm Sci. 2016;40(2):141–4.Google Scholar
  4. 4.
    Zhang Z, Hu Y, Zou G, Lin M, Zeng J, Deng S, et al. Antibiotic prescribing for upper respiratory infections among children in rural China: a cross-sectional study of outpatient prescriptions. Glob Health Action. 2017;10(1):1287334.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Yuan S. China should reduce the overuse of intravenous infusion. BMJ. 2014;348:g1262.CrossRefPubMedGoogle Scholar
  6. 6.
    2018 Annual Report of China’s National Report on Adverse Reaction Monitoring. Accessed 5 Aug 2019.
  7. 7.
    Zhao Y, Wang T, Li G, Sun S. Pharmacovigilance in China: development and challenges. Int J Clin Pharm. 2018;40(4):823–31.CrossRefPubMedGoogle Scholar
  8. 8.
    Li X, Thai S, Lu W, Sun S, Tang H, Zhai S, et al. Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database. Int J Clin Pharm. 2018;40(4):921–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Lobo DN, Dube MG, Neal KR, Simpson J, Rowland BJ, Allison SP. Problems with solutions: drowning in the brine of inadequate knowledge base. Clin Nutr. 2001;20:125–30.CrossRefPubMedGoogle Scholar
  10. 10.
    Reynolds L, McKee M. Serve the people or close the sale? Profit-driven overuse of injections and infusions in China’s market-based healthcare system. Int J Health Plan Manag. 2011;26(4):449–70.CrossRefGoogle Scholar
  11. 11.
    Kan J, Zhu X, Wang T, Lu R, Spencer PS. Chinese patient demand for intravenous therapy: a preliminary survey. The Lancet. 2015;386:S61.CrossRefGoogle Scholar
  12. 12.
    Alotaibi YK, Federico F. The impact of health information technology. Saudi Med J. 2017;38(12):1173–80.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Wang D, Gong Z, Lei G. Design and practice of rational and safe intravenous infusion integration management. Chin Hosp. 2018;22(8):57–8.Google Scholar
  14. 14.
    National Clinical Guideline Centre (UK). Intravenous fluid therapy in adults in hospital. Accessed 5 Aug 2019.
  15. 15.
    Zeng S, Chen X, Liu W, Yin T, Gong Z. Medication analysis of intravenous infusion in critically ill patients in a hospital. Chin Hosp Pharm J. 2018;38(16):1750–4.Google Scholar
  16. 16.
    Zeng S, Wang D, Liu W, Gong Z. Integration management practice of rational and safe infusion based on the “medicine–pharmacy–nursing” monitor-control and early warning system. Chin Hosp Pharm J. 2019;39(7):98–103.Google Scholar
  17. 17.
    Li H, Wang S, Yue Z, Ren X, Xia J. Traditional Chinese herbal injection: current status and future perspectives. Fitoterapia. 2018;129:249–56.CrossRefPubMedGoogle Scholar
  18. 18.
    Basic Principles for Clinical Use for TCM injections. Accessed 5 Aug 2019.
  19. 19.
    Pérez Fidalgo JA, Garcia Fabregat L, Cervantes A, Margulies A, Vidall C, Roila F, et al. Management of chemotherapy extravasation: ESMO–EONS clinical practice guidelines. Eur J Oncol Nurs. 2012;16(5):528–34.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Pharmacy, Xiangya HospitalCentral South UniversityChangshaChina
  2. 2.Institute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya HospitalCentral South UniversityChangshaChina
  3. 3.Department of Social Medicine and Health Management, Xiangya School of Public HealthCentral South UniversityChangshaChina
  4. 4.Department of Nursing, Xiangya HospitalCentral South UniversityChangshaChina
  5. 5.Department of Pharmacy Practice, College of Pharmacy and Health SciencesWestern New England UniversitySpringfieldUSA

Personalised recommendations